| Product NDC: | 14783-550 |
| Proprietary Name: | LBel |
| Non Proprietary Name: | Octinoxate, Octisalate, Octocrylene, Oxybenzone, and Titanium dioxide |
| Active Ingredient(s): | .075; .04; .1; .06; .01 g/g; g/g; g/g; g/g; g/g & nbsp; Octinoxate, Octisalate, Octocrylene, Oxybenzone, and Titanium dioxide |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | CREAM |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 14783-550 |
| Labeler Name: | Ventura International, Limited |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part352 |
| Marketing Category: | OTC MONOGRAPH NOT FINAL |
| Start Marketing Date: | 20110419 |
| Package NDC: | 14783-550-06 |
| Package Description: | 1 BOTTLE in 1 CARTON (14783-550-06) > 5 g in 1 BOTTLE (14783-550-05) |
| NDC Code | 14783-550-06 |
| Proprietary Name | LBel |
| Package Description | 1 BOTTLE in 1 CARTON (14783-550-06) > 5 g in 1 BOTTLE (14783-550-05) |
| Product NDC | 14783-550 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Octinoxate, Octisalate, Octocrylene, Oxybenzone, and Titanium dioxide |
| Dosage Form Name | CREAM |
| Route Name | TOPICAL |
| Start Marketing Date | 20110419 |
| Marketing Category Name | OTC MONOGRAPH NOT FINAL |
| Labeler Name | Ventura International, Limited |
| Substance Name | OCTINOXATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE; TITANIUM DIOXIDE |
| Strength Number | .075; .04; .1; .06; .01 |
| Strength Unit | g/g; g/g; g/g; g/g; g/g |
| Pharmaceutical Classes |